Cd20 (pan‐B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes
Open Access
- 1 January 1993
- Vol. 14 (2) , 196-204
- https://doi.org/10.1002/cyto.990140212
Abstract
Despite the previous description of the leukocyte differentiation antigen CD20 as B cell restricted, the findings reported here indicate that a small subset of human T cells expresses low levels of CD20 or a cross-reacting antigen. Three different CD20 monoclonal antibodies (mAb), Leu16, B1, and 1F5, reacted with the T cell subset. B cells that expressed CD20 were CD20bright and constituted an average of 9.2 ± 3.3% of adult PBL. Meanwhile, T cells that expressed CD20 were CD20dim and represented 2.4 ± 1.5% of the PBL. This population may have been overlooked in previous studies due to the low level of CD20 expression per T cell and the small size of the subset in most individuals. Blocking studies indicated that CD20 mAb binding to CD3+ cells was due to the antigen-reactive regions of the CD20 antibodies and was not a result of Fc receptor binding, or non-specific fluorochrome or protein binding. The T cell nature of the CD20dim CD3+ cells was confirmed by the rapid rise in the intracellular calcium concentration ([Ca2+]i) of CD20dim cells observed following treatment with CD3 mAb but not following treatment with anti-human immunoglobulin (Ig). Extensive three-color immunophenotypic analyses indicated that CD20dim T cells were phenotypically heterogeneous and displayed a leukocyte differentiation profile that was slightly different than that of CD20− T cells. Thus, the CD20dim T cells were more likely than CD20− T cells to be γ/δ T cell antigen receptor positive (14% vs. 3.4%), CD8+ (57% vs. 33%), and CD45RO+ (82% vs. 51%); fewer were CD38+ (5% vs. 24%) or CD4+ (35% vs. 61%). Given that most differentiation antigens expressed on leukocytes participate in the functions of the cells that express them, it is possible that CD20 plays a role on the T cells on which it is expressed, although the function(s) of the CD20 molecule on T and B cells remains unknown.Keywords
This publication has 25 references indexed in Scilit:
- Quality control in the flow cytometric measurement of T-lymphocyte subsets: The Multicenter AIDS Cohort Study experienceClinical Immunology and Immunopathology, 1990
- Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formationEuropean Journal of Immunology, 1988
- Conversion of logarithmic channel numbers into relative linear fluorescence intensityCytometry, 1988
- Analysis of two cDNA clones encoding the B lymphocyte antigen CD20 (B1, Bp35), a type III integral membrane protein.The Journal of Experimental Medicine, 1988
- Isolation and structure of a cDNA encoding the B1 (CD20) cell-surface antigen of human B lymphocytes.Proceedings of the National Academy of Sciences, 1988
- Expression of the human B-cell surface protein CD20: alteration by phorbol 12-myristate 13-acetate.Proceedings of the National Academy of Sciences, 1987
- Role of the Bp35 cell surface polypeptide in human B-cell activation.Proceedings of the National Academy of Sciences, 1985
- B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.Journal of Clinical Investigation, 1984
- Cell membrane perturbation of resting T cells and thymocytes causes display of activation antigens.The Journal of Experimental Medicine, 1983
- Comparative expression of T9, T10, and Ia antigens on activated human T cell subsetsHuman Immunology, 1981